SCHEMBL3852403

SCHEMBL3852403

CC(=O)NC1=CC(=O)C=CC1=Nc1c(C)n(C)n(-c2ccccc2)c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.59
▸ GAA P10253 7/20 0.59
▸ KMT2A Q03164 7/20 0.59
▸ MEN1 O00255 6/20 0.59
▸ ALDH1A1 P00352 5/20 0.59
▸ KDM4E B2RXH2 4/20 0.59
▸ MPI P34949 3/20 0.59
▸ THRB P10828 3/20 0.59
▸ BLM P54132 1/20 0.59
▸ MAPK1 P28482 6/20 0.57
▸ HTT P42858 3/20 0.57
▸ POLB P06746 2/20 0.57
▸ NPSR1 Q6W5P4 2/20 0.57
▸ MITF O75030 1/20 0.57
▸ NSD2 O96028 1/20 0.57
▸ OPRK1 P41145 1/20 0.57
▸ LMNA P02545 2/20 0.52
▸ ATM Q13315 1/20 0.52
▸ TDP1 Q9NUW8 2/20 0.50
▸ TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852399 1.00 MAPT (0.59) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL3861001 0.91 MAPT (0.54) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL3861002 0.91 MAPT (0.54) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL3858944 0.81 MAPT (0.70) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL3858947 0.81 MAPT (0.70) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL13679925 0.81 MAPT (0.70) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL3859551 0.79 MAPT (0.67) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL3859550 0.79 MAPT (0.67) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL13963839 0.79 MAPT (0.67) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL13679931 0.77 MAPT (0.50) MAPTGAAKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 — — US disclosed
EP-2011787-A1 Dying composition comprising an azomethin-type compound with a pyrazolinone moiety L'Oreal (FR) 2009-01-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit KRT18, KMO, TMPO MAPT 308/4885GAA 4421/4885KMT2A 1831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback